Carlo Bifulco, Chief Medical Officer at Providence Genomics
0:00 Only 1 out of 2 patients nationwide seeing benefits of genomic profiling in cancer
7:45 What is the state of the art at Providence?
14:18 Are pathologists on board?
20:22 Do patients come in knowing about CGP?
24:43 Where to from here?
Carlo Bifulco joins us today. He’s an Italian who helped persuade one of America’s largest not-for-profit health systems that providing more genomic information to cancer patients early on was the right thing. With 52 hospitals, over 1,000 physician clinics, more than 120,000 caregivers serving communities across seven states—Alaska, California, Montana, New Mexico, Oregon, Texas, and Washington—Providence and Carlo have quite a task ahead. We ask Carlo what is the state of comprehensive genomic profiling at Providence today?